Rocket Pharmaceuticals, Inc. (RCKT)
3.00
-0.07
(-2.28%)
USD |
NASDAQ |
May 19, 09:58
Rocket Pharmaceuticals Research and Development Expense (Quarterly) : 30.17M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AnaptysBio, Inc. | 33.86M |
| Arcus Biosciences, Inc. | 122.00M |
| Replimune Group, Inc. | 52.87M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |
| Alnylam Pharmaceuticals, Inc. | 364.87M |